nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—Epinephrine—TNF—narcolepsy	0.0179	1	CrCbGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00328	0.00334	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00321	0.00327	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—HRH3—narcolepsy	0.00307	0.00313	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00305	0.00311	CbGpPWpGaD
Dipivefrin—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00301	0.00307	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—HCRT—narcolepsy	0.003	0.00305	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00299	0.00304	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00298	0.00304	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00298	0.00303	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00298	0.00303	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00296	0.00301	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00294	0.003	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00288	0.00293	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00286	0.00292	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00285	0.0029	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—HCRT—narcolepsy	0.0028	0.00285	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00279	0.00284	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.00277	0.00282	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.00277	0.00282	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00276	0.00281	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00267	0.00272	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00267	0.00272	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00267	0.00272	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—PENK—narcolepsy	0.00267	0.00272	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00266	0.00271	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00264	0.00268	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00262	0.00266	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00258	0.00263	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.0025	0.00254	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—PENK—narcolepsy	0.00249	0.00254	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00249	0.00254	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00247	0.00251	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00245	0.00249	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00244	0.00249	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00244	0.00248	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00239	0.00243	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00239	0.00243	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00232	0.00236	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00227	0.00231	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—TRH—narcolepsy	0.00227	0.00231	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00226	0.0023	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00224	0.00228	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00218	0.00222	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00217	0.00221	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00217	0.00221	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00214	0.00218	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00214	0.00218	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00214	0.00217	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—TRH—narcolepsy	0.00212	0.00216	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00206	0.0021	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00206	0.0021	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00204	0.00207	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00204	0.00207	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00203	0.00206	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00202	0.00206	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00202	0.00206	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00199	0.00203	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—HRH3—narcolepsy	0.00199	0.00203	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00198	0.00202	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00197	0.002	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00197	0.002	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00193	0.00196	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00193	0.00196	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00187	0.00191	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00187	0.00191	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—P2RY11—narcolepsy	0.00186	0.00189	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—HRH3—narcolepsy	0.00186	0.00189	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00185	0.00189	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00185	0.00188	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00185	0.00188	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CHKB—narcolepsy	0.00181	0.00184	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—P2RY11—narcolepsy	0.00181	0.00184	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00179	0.00182	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00177	0.0018	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00177	0.0018	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00175	0.00178	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00175	0.00178	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00172	0.00175	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HCRT—narcolepsy	0.00169	0.00172	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—P2RY11—narcolepsy	0.00169	0.00172	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00168	0.00171	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00168	0.00171	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00167	0.0017	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—TAC1—narcolepsy	0.00165	0.00168	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—NPS—narcolepsy	0.00165	0.00168	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00164	0.00167	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00164	0.00167	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00163	0.00166	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00163	0.00166	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00163	0.00166	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00163	0.00166	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CHKB—narcolepsy	0.00162	0.00165	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00161	0.00164	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HCRT—narcolepsy	0.00158	0.00161	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00156	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00156	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—NPS—narcolepsy	0.00154	0.00157	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—TAC1—narcolepsy	0.00154	0.00157	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HCRT—narcolepsy	0.00154	0.00157	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00153	0.00156	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00153	0.00156	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00152	0.00155	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.00152	0.00155	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00151	0.00154	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00151	0.00154	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—PENK—narcolepsy	0.00151	0.00154	CbGpPWpGaD
Dipivefrin—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0015	0.00153	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00149	0.00152	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00148	0.0015	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00144	0.00146	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HCRT—narcolepsy	0.00144	0.00146	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00142	0.00145	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.00142	0.00145	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.00142	0.00145	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—PENK—narcolepsy	0.00141	0.00144	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CHKB—narcolepsy	0.0014	0.00143	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00138	0.00141	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00137	0.0014	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—PENK—narcolepsy	0.00137	0.0014	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00135	0.00138	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00135	0.00137	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00135	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0013	0.00133	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00129	0.00131	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.00128	0.00131	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TRH—narcolepsy	0.00128	0.00131	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—PENK—narcolepsy	0.00128	0.0013	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00127	0.00129	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00126	0.00128	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.00125	0.00127	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.00125	0.00127	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00124	0.00127	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00123	0.00125	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CPT1B—narcolepsy	0.00123	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00122	0.00124	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TRH—narcolepsy	0.0012	0.00122	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.00117	0.00119	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TRH—narcolepsy	0.00117	0.00119	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00115	0.00118	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00115	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.00115	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CHKB—narcolepsy	0.00114	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HRH3—narcolepsy	0.00113	0.00115	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00112	0.00114	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00111	0.00113	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HCRTR2—narcolepsy	0.00111	0.00113	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HCRTR1—narcolepsy	0.00111	0.00113	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CPT1B—narcolepsy	0.0011	0.00112	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00109	0.00111	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00109	0.00111	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TRH—narcolepsy	0.00109	0.00111	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—P2RY11—narcolepsy	0.00107	0.00109	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00106	0.00108	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00105	0.00107	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HRH3—narcolepsy	0.00105	0.00107	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00105	0.00107	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.00104	0.00106	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HCRTR2—narcolepsy	0.00103	0.00105	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HCRTR1—narcolepsy	0.00103	0.00105	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HRH3—narcolepsy	0.00102	0.00104	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00101	0.00103	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.001	0.00102	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—P2RY11—narcolepsy	0.000998	0.00102	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—HTR2A—narcolepsy	0.000993	0.00101	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000989	0.00101	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00098	0.000998	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.000974	0.000991	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HRH3—narcolepsy	0.000955	0.000972	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CPT1B—narcolepsy	0.000954	0.000972	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.000952	0.000969	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TAC1—narcolepsy	0.000933	0.000949	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—NPS—narcolepsy	0.000933	0.000949	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—HTR2A—narcolepsy	0.000927	0.000944	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.000921	0.000937	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.000921	0.000937	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.000919	0.000936	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HCRT—narcolepsy	0.000908	0.000925	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000903	0.00092	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000903	0.00092	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.000897	0.000913	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000884	0.0009	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.000872	0.000888	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TAC1—narcolepsy	0.000871	0.000887	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—NPS—narcolepsy	0.000871	0.000887	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000854	0.000869	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HCRT—narcolepsy	0.000849	0.000864	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TAC1—narcolepsy	0.000847	0.000862	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—NPS—narcolepsy	0.000847	0.000862	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.000839	0.000855	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.000839	0.000855	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.000836	0.000851	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.000836	0.000851	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.000835	0.00085	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.000811	0.000825	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.000811	0.000825	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PENK—narcolepsy	0.00081	0.000824	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PENK—narcolepsy	0.000799	0.000814	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—NPS—narcolepsy	0.000791	0.000805	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TAC1—narcolepsy	0.000791	0.000805	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.000775	0.000789	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CPT1B—narcolepsy	0.000775	0.000789	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.000761	0.000775	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.000761	0.000775	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PENK—narcolepsy	0.000756	0.00077	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000753	0.000767	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.000742	0.000755	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000708	0.00072	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000708	0.00072	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000691	0.000704	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000691	0.000704	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000689	0.000702	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TRH—narcolepsy	0.000688	0.000701	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00068	0.000692	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000661	0.000673	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TRH—narcolepsy	0.000643	0.000655	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000642	0.000654	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000642	0.000654	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.000614	0.000626	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HRH3—narcolepsy	0.000604	0.000615	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.000596	0.000607	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HRH3—narcolepsy	0.000564	0.000574	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000562	0.000572	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000561	0.000571	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.000554	0.000564	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000524	0.000534	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000522	0.000532	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HTR2A—narcolepsy	0.000509	0.000519	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000503	0.000512	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NPS—narcolepsy	0.0005	0.000509	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TAC1—narcolepsy	0.0005	0.000509	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000494	0.000503	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000494	0.000503	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000493	0.000502	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HTR2A—narcolepsy	0.000476	0.000485	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TAC1—narcolepsy	0.000467	0.000476	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NPS—narcolepsy	0.000467	0.000476	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000458	0.000466	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000458	0.000466	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000426	0.000433	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000416	0.000424	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000408	0.000416	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000408	0.000416	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000387	0.000394	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.00038	0.000386	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.00038	0.000386	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HTR2A—narcolepsy	0.000301	0.000306	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000297	0.000302	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HTR2A—narcolepsy	0.000281	0.000286	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000246	0.00025	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000228	0.000232	CbGpPWpGaD
